Все публикации

Distinguishing AML Symptoms and Side Effects | Why Communication Is Essential

Updates in Myelofibrosis Research From an Expert

What Role Does Exercise Play in Cancer Treatment?

Essential Genetic Testing for Personalized Gynecologic Cancer Treatment

Peer Insights | The Power of Patient-Centered Care

HCP Roundtable: Fine-Tuning CLL Dose Modification and Side Effect Management Strategies

Treating Non-Melanoma Skin Cancer With Targeted Therapies

When Should Clinical Trials Be Considered for Advanced Non-Melanoma Skin Cancer Treatment?

HCP Roundtable: Breaking Through Myelofibrosis Practice Barriers

Potential Impact of Artificial Intelligence on Stomach Cancer Detection and Care

Do Disparities Exist for Black and Latinx Veterans Facing Lung Cancer?

What AML Patients Should Understand About Test Results

Lung Cancer Strategies for Veterans | Research and Care Insights

Catalyzing Lung Cancer Care | The Transformative Impact of Early Biomarker Testing

How Can Prostate Cancer Collaborative Care Be Coordinated?

Care Partners | What Should You Know About the Bispecific Antibody Treatment for Myeloma?

Primary vs Secondary Myelofibrosis | What’s the Difference?

What Are the Currently Approved Myelofibrosis Therapies?

How is Treatment Fitness Determined in Multiple Myeloma?

What Are Potential Comorbidities in Follicular Lymphoma?

Understanding Unique Barriers Faced by Myeloma Research Nurses

What Is the Role of Bispecific Antibody Therapy in the Future of Myeloma Care?

How Can Extensive Stage Small Cell Lung Cancer Symptoms Be Managed?

Myeloproliferative Neoplasm News and Research Updates